Market Synopsis of the Global Nonallergic Rhinitis Market
Rising prevalence of nonallergic rhinitis, and increasing demand for diagnosis and treatment of nonallergic rhinitis are the major factors driving the growth of the market across the globe. Furthermore, increasing healthcare expenditure and overall growth of healthcare industry also influences the market growth. Splendid research in the field of immunology also boost the market. Additionally, increasing focus on the development of new medications for the treatment of nonallergic rhinitis, and increasing use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) also fuel the market growth.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5137
The Nonallergic Rhinitis Market growth of the market is restricted by increasing competition among key players in the market that act as a barrier of new entrants. The Global Nonallergic Rhinitis Market report is a professional in-depth analysis report which explores detail overview of some of the key players in this market which are Boehringer Ingelheim GmbH (Germany), Novartis (U.S.), GlaxoSmithKline (U.K), Perrigo Company plc (Ireland), Johnson & Johnson Consumer Inc. (U.S.), Bayer (U.S.), Sanofi (France) and others.
The global nonallergic rhinitis market is expected to grow at a CAGR of 5.3% during the forecast period.
Key Players in the Global Nonallergic Rhinitis Market
- Boehringer Ingelheim GmbH (Germany)
- Novartis (U.S.)
- GlaxoSmithKline (U.K)
- Perrigo Company plc (Ireland)
- Johnson & Johnson Consumer Inc. (U.S.)
- Bayer (U.S.)
- Sanofi (France)
Regional Analysis of the Global Nonallergic Rhinitis Market
America holds the first position in the market for nonallergic rhinitis owing to the rising prevalence of nonallergic rhinitis in the U.S., and consequent increase in the demand for new diagnostic and treatment services. In Americas, North America is the largest market owing to the presence of key players in the industry. As per the Warren Alpert Medical School of Brown University, the prevalence of nonallergic rhinitis has been observed to be one-third that of allergic rhinitis, affecting ~7% of the U.S. population or ~22 million people. Additionally, rising awareness about morbidity due to nonallergic rhinitis and the presence of key players in the market also influence the growth of the market.
The Middle East & Africa also show a steady rise in the market owing to low prevalence of nonallergic rhinitis and increasing awareness about allergic and nonallergic rhinitis treatment. In the Middle East & Africa, the Middle East captures the largest market share for availability of specialty medical services and increasing expenditure on healthcare
Europe is the second largest market for nonallergic rhinitis. In Europe, there is an increasing demand for nasal sprays, and extensive research and development activities by clinical research and academic institutes for chronic diseases treatment. Germany, and France are the largest contributors to the market growth owing to an increase in the number of market players manufacturing NSAIDs, and overall growth of healthcare industry.
The market in Asia Pacific is expected to grow at the fastest pace and is driven by an increasing number of patients suffering from nonallergic rhinitis and increasing awareness about the diagnosis and treatment. India, China, and Japan are major contributors to the growth of the market. This growth is attributed to an increasing demand for nasal sprays and OTC medicines and availability of highly qualified medical personnel dedicated to the research of chronic diseases.
Segments
The global nonallergic rhinitis market is segmented on the basis of diagnosis, treatment, and end user.
On the basis of diagnosis, market is categorized into physical examination, allergy testing, imaging test, and other segments. Allergy testing is further segmented into skin test and blood test. Imaging test is further segmented into nasal endoscopy, and computerized tomography (CT) Scan.
Nasal sprays is further segmented into saline, corticosteroid, antihistamine, decongestants, and anti-drip anticholinergic.
On the basis of end user, the market is segmented into hospitals & clinics, research centers, and others.
On the basis of treatment, the market is segmented into nasal sprays, NSAIDs and others.
Browse Complete 110 Pages Premium Research Report Enabled with 65 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/nonallergic-rhinitis-market-5137
Detailed Table of Contents:
Table Of Contents
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
… Continued!
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment